Hepatitis E Virus ORF1 Polyprotein Harbors a Pocket‐Like Cavity That Is Vital for Virus Replication and Represents a Novel Antiviral Target
Advanced Science · 2025
DOI: 10.1002/advs.202501699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaohui Ding und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, Xuzhou Medical University, Xuzhou, 221004, China. Hauptthemen laut MEDLINE: Hepatitis E virus, Virus Replication, Polyproteins, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis worldwide, yet no FDA‐approved anti‐HEV medication available. Elucidating HEV replication machinery is therefore crucial for identifying novel antiviral targets, and consequently developing potent antivirals. The nonstructural ORF1 polyprotein is pivotal for HEV replication. Herein, it is revealed that the ORF1 X domain is a critical component of HEV replication machinery. Interestingly, the ADP‐ribose hydrolase activity of X domain per se is dispensable for HEV replication. Instead, the X domain supports HEV replication through its interdomain interaction with the RNA‐dependent RNA polymerase (RdRp). Structure‐based functional analysis reveals that X and RdRp jointly create a “pocket‐like” cavity (PC) at their interaction interface. Site‐directed mutagenesis disrupting the PC integrity completely abolishes HEV replication, demonstrating its crucial role in the viral life cycle. Through a PC‐targeted high‐throughput in silico screening pipeline, combined with molecular docking analysis, surface plasmon resonance assays, and advanced in vitro HEV models, saikosaponin D and liriopesides B are identified as potent HEV inhibitors targeting this critical interface. Collectively, this study identifies a novel structure within ORF1 polyprotein that is crucial for HEV replication, and demonstrates the feasibility of developing novel antivirals by targeting this PC structure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, Xuzhou Medical University, Xuzhou, 221004, China.
- Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, 221004, China.
- Jiangsu Key Laboratory of Brain Disease and Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, 221004, China.
Zitieren
APA
Ding, X., Zeng, D., Liu, D., Bian, Y., Li, B., Li, Z., Li, Q., Liang, S., Si, Y., Yao, Q., Ding, Y., Zhu, J., Li, X., Zheng, K., Guo, H., & Wang, W. (2025). Hepatitis E Virus ORF1 Polyprotein Harbors a Pocket‐Like Cavity That Is Vital for Virus Replication and Represents a Novel Antiviral Target. Advanced Science. https://doi.org/10.1002/advs.202501699
Vancouver
Ding X, Zeng D, Liu D, Bian Y, Li B, Li Z, et al. Hepatitis E Virus ORF1 Polyprotein Harbors a Pocket‐Like Cavity That Is Vital for Virus Replication and Represents a Novel Antiviral Target. Advanced Science. 2025. doi:10.1002/advs.202501699
BibTeX
@article{Ding2025,
author = {Ding, Xiaohui and Zeng, Dou and Liu, Dan and Bian, Yingying and Li, Bin and Li, Zheng and Li, Qiudi and Liang, Shiquan and Si, Yunlong and Yao, Qili and Ding, Yibo and Zhu, Jiahui and Li, Xiangyang and Zheng, Kuiyang and Guo, Hongbo and Wang, Wenshi},
title = {Hepatitis E Virus ORF1 Polyprotein Harbors a Pocket‐Like Cavity That Is Vital for Virus Replication and Represents a Novel Antiviral Target},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501699}
}
EUVIMED